This HTML5 document contains 202 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.2165/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11https://scigraph.springernature.com/pub.10.2165/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37079088
rdf:type
wikibase:Item
schema:description
vědecký článek articolo scientifico ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2008年學術文章 מאמר מדעי 2008年学术文章 سائنسی مضمون wetenschappelijk artikel 2008年學術文章 2008年の論文 scientific article published on January 2008 2008年学术文章 artikull shkencor bài báo khoa học научная статья مقالهٔ علمی 2008 nî lūn-bûn บทความทางวิทยาศาสตร์ artigo científico სამეცნიერო სტატია tudományos cikk 2008年学术文章 wissenschaftlicher Artikel vedecký článok мақолаи илмӣ mokslinis straipsnis artigo científico (publicado na 2008) 2008年學術文章 2008年学术文章 videnskabelig artikel (udgivet 2008) επιστημονικό άρθρο 2008年學術文章 naučni članak artículu científicu espublizáu en 2008 tieteellinen artikkeli научни чланак مقالة علمية نشرت في يناير 2008 vitskapeleg artikkel 2008年學術文章 artikulong pang-agham 2008년 논문 наукова стаття, опублікована в січні 2008 articol științific vetenskaplig artikel scienca artikolo bilimsel makale artículo científico publicado en 2008 научни чланак գիտական հոդված vitenskapelig artikkel article scientifique publié en 2008 мақолаи илмӣ научна статия artigo científico (publicado na 2008) article scientific artykuł naukowy 2008年学术文章 article científic 2008年學術文章 teaduslik artikkel
p:P577
wds:Q37079088-F7FDAC3C-26A2-4E9A-86A1-4BBBDCAC45F9
wdt:P577
2008-01-01T00:00:00Z
p:P2888
wds:Q37079088-CA3902D3-2E57-4AD8-BD6A-8031FE5B72D5
wdt:P2888
n11:00002512-200825020-00005
p:P2860
wds:Q37079088-FFA77827-3C96-4981-ACF9-B055A906E182 wds:Q37079088-D720FF71-9AC3-4CD2-88C6-3EFE77761190 wds:Q37079088-D7E5234F-B304-4F80-BD4D-2AF3183B832C wds:Q37079088-D975FCAB-6DDE-4BB3-8482-06F86422C558 wds:Q37079088-DAD2F1EF-CC81-4F42-A188-F1B4ECDF27CE wds:Q37079088-D0A5774E-80FC-41FE-9BAA-65E19BFB28D4 wds:Q37079088-D11596B1-94A4-4D49-A180-716E8E2DF03A wds:Q37079088-D196D69E-355B-41F1-B26E-62C267CDE470 wds:Q37079088-A1165E01-8787-44A4-914D-BB27E3077F0B wds:Q37079088-A2E061A6-148C-4E8E-A974-471C289D41F1 wds:Q37079088-B206C86C-4D26-4FF7-A33E-27B30A37ED3E wds:Q37079088-8D4B29F5-C90D-4995-B037-72E33B5986AA wds:Q37079088-8DE8E5CD-1028-4C54-8A13-9AAC52D8B4F0 wds:Q37079088-98704922-9207-4B05-BFEA-749FD92DCAAC wds:Q37079088-9B8F0B3B-C92F-4E46-82BD-6095F3A56BD3 wds:Q37079088-F466094B-B5FA-46CA-BCCD-6DDC2BCABC65 wds:Q37079088-EF66BC07-4093-4ADE-87C3-36AE465DE6F3 wds:Q37079088-F31B2B54-33CB-46CA-8633-DE49C789A9AE wds:Q37079088-F3CF1203-BBD4-4354-B39B-13DA626D6345 wds:Q37079088-E97B4117-5C4F-487B-A31B-46EA8C726D26 wds:Q37079088-EB728B12-2B78-4F72-8AD1-7A80202CADF3 wds:Q37079088-EC55AAA9-524B-4470-9547-936539B65610 wds:Q37079088-EEFD685B-CCF7-4147-8D6E-30409034D692 wds:Q37079088-DB3DAEDA-1B3A-41C6-965B-477CFBA8C113 wds:Q37079088-DCBA0DA3-32DE-4E21-B6A3-060A4142E41E wds:Q37079088-E0449B3D-5D3D-4AB4-996D-CF14D78B54DA wds:Q37079088-E915C263-CFB0-4ED8-9C59-113851FC6AEE wds:Q37079088-45FAC422-7E8A-429D-BCDD-17894F29D195 wds:Q37079088-471CC4B9-A94E-41D5-B073-A2868FB7ADCB wds:Q37079088-473AFE63-0099-404D-877C-DD97BE4C87C5 wds:Q37079088-48FE16EB-CECF-41B5-B6B0-865485E94AF3 wds:Q37079088-30B2C6C4-90B5-45D8-BC7F-2E3D4BF57361 wds:Q37079088-31A699E9-297D-455D-A272-94E812F6E17E wds:Q37079088-2194AE9C-F544-4122-BE2D-C1A6FDC7FD0D wds:Q37079088-223E3270-8F02-4769-B97A-9056C6B967A4 wds:Q37079088-1AED36A1-30FE-45A3-B05C-F2FD2627DA3F wds:Q37079088-7E3425FA-ED90-4992-8505-EB9EF215EDC9 wds:Q37079088-7FD06AF7-80A1-42E8-A1B5-7E77BFFDC0F5 wds:Q37079088-8515E34A-F000-4EDB-A771-1DFE76D6C447 wds:Q37079088-85AD54F5-D69F-4249-944D-35C5527E0620 wds:Q37079088-6DBAF6D6-8FC0-43BB-A60B-8C470A7354FE wds:Q37079088-755E88AE-57EB-4ED2-A46F-F23D25EC42F7 wds:Q37079088-7DC99492-FDF0-4AA6-9786-DE53681E42E7 wds:Q37079088-53AA8667-1AAB-493B-91E7-FD85D517C359 wds:Q37079088-5B8CEEBC-FADA-4B38-801E-AFE8E279249D wds:Q37079088-6B84761E-1263-4F90-BE25-63B430F8B15B wds:Q37079088-4D87C82A-6CCE-497C-9D72-6C022F2F8CF9 wds:Q37079088-507945B6-CC0A-4FFC-955B-EAE61A32C781 wds:Q37079088-5082CA6A-FA26-447E-8B2D-9A16DBBBFAD1 wds:Q37079088-5277E25F-295A-4EA6-96FB-0B070BB01466
wdt:P2860
wd:Q57007908 wd:Q34517399 wd:Q46375440 wd:Q44301257 wd:Q57630939 wd:Q29614692 wd:Q44550635 wd:Q70789836 wd:Q68321680 wd:Q58975659 wd:Q36707813 wd:Q50868953 wd:Q69894212 wd:Q80223333 wd:Q36329274 wd:Q69413939 wd:Q74670653 wd:Q44603498 wd:Q81224327 wd:Q36421037 wd:Q36406212 wd:Q36479365 wd:Q34706848 wd:Q35882974 wd:Q53598927 wd:Q34450364 wd:Q24245649 wd:Q43636298 wd:Q24670735 wd:Q43777416 wd:Q35871797 wd:Q44175906 wd:Q77109820 wd:Q69021341 wd:Q45332974 wd:Q35377431 wd:Q41724202 wd:Q68759416 wd:Q36162987 wd:Q34447166 wd:Q44933278 wd:Q77913721 wd:Q35113299 wd:Q46262235 wd:Q35771399 wd:Q68437494 wd:Q42084371 wd:Q35562104 wd:Q47691340 wd:Q35638083
p:P2093
wds:Q37079088-66FC8184-74D1-425B-ADA8-B12655EB64B1 wds:Q37079088-28C45B5C-731E-4CAF-B055-973FA87480C7
wdt:P2093
Joyce V Loyed Miranda R Andrus
rdfs:label
Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues
skos:prefLabel
Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues
schema:name
Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues
p:P1476
wds:Q37079088-0325B227-B157-482C-9C31-2C6172CE0A52
wdt:P1476
Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues
p:P304
wds:Q37079088-B66530B8-9655-4CBC-BD42-8D0F35DCB418
wdt:P304
131-144
p:P31
wds:Q37079088-c144fccf-10b5-49ec-87cf-b8afa4f0eeb1 wds:Q37079088-F4473340-D9F5-4C89-8B62-899FD5A2CC54
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q37079088-F3C26125-08DD-4BE1-A06D-0E2CF4D52EAA wds:Q37079088-F624A72A-A83D-4F91-9E97-8B1CF4E790CF
wdt:P921
wd:Q11068 wd:Q199804
p:P698
wds:Q37079088-40BAADC3-F129-4AB2-919C-F719C1D015E9
wdtn:P698
n10:18257600
wdt:P698
18257600
p:P1433
wds:Q37079088-0F8386E2-EF28-423C-A041-9237D2EB28A3
wdt:P1433
wd:Q5308946
p:P433
wds:Q37079088-6BA333D8-5BCD-45B8-BC00-C7BA29DECF29
p:P478
wds:Q37079088-28D6EF0C-CCC6-4AE8-96F8-9E08665EF335
wdt:P433
2
wdt:P478
25
p:P356
wds:Q37079088-3C0D279A-7BBD-435E-B869-AEB180E79A97
wdtn:P356
n12:00002512-200825020-00005
wdt:P356
10.2165/00002512-200825020-00005